Sunovion Announces U.S. FDA Approval of KYNMOBI™ (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson’s Disease OFF Episodes
– First and only sublingual therapy approved for the on-demand treatment of Parkinson’s disease OFF episodes – – In a…